BDX Logo

Becton, Dickinson and Company (BDX) 

NYSE
Market Cap
$64.98B
Sector
Healthcare
Industry
Medical—Instruments & Supplies
Rank in Sector
341 of 774
Rank in Industry
24 of 48

Largest Insider Buys in Sector

BDX Stock Price History Chart

BDX Stock Performance

About Becton, Dickinson and Company

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer …

Insider Activity of Becton, Dickinson and Company

Over the last 12 months, insiders at Becton, Dickinson and Company have bought $0 and sold $2.9M worth of Becton, Dickinson and Company stock.

On average, over the past 5 years, insiders at Becton, Dickinson and Company have bought $0 and sold $12.79M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 30 shares for transaction amount of $7,439 was made by BURZIK CATHERINE M (director) on 2019‑04‑16.

List of Insider Buy and Sell Transactions, Becton, Dickinson and Company

2024-06-10SaleSVP,Controller&Chief Acct Off
300
0.0001%
$239.31$71,793-1.67%
2024-05-15SaleEVP and President EMEA
3,300
0.0011%
$236.73$781,224-0.75%
2024-05-13SaleEVP and President EMEA
3,300
0.0011%
$236.70$781,121-0.60%
2024-04-30SaleEVP & President Medical
1,715
0.0006%
$232.81$399,269+0.40%
2024-03-14SaleSVP,Controller&Chief Acct Off
282
<0.0001%
$238.29$67,198-0.64%
2023-12-11SaleEVP & President Medical
1,239
0.0004%
$232.46$288,018+1.74%
2023-11-28SaleEVP & President Interventional
2,156
0.0007%
$238.47$514,141-0.26%
2023-09-05SaleEVP & President Interventional
459
0.0002%
$274.48$125,986-12.73%
2023-08-28Saledirector
848
0.0003%
$281.66$238,848-15.36%
2023-08-11SaleEVP & President, Life Sciences
2,974
0.001%
$277.85$826,326-15.40%
2023-08-08SaleEVP & President Medical
1,300
0.0005%
$277.13$360,269-15.02%
2023-02-03SaleEVP & President Interventional
1,421
0.0005%
$248.60$353,261+3.07%
2022-08-15SaleChairman, CEO and President
9,500
0.0033%
$265.13$2.52M-5.02%
2022-08-15SaleEVP & President, Life Sciences
475
0.0002%
$265.00$125,875-5.02%
2022-08-09SaleExecutive Vice President
1,652
0.0006%
$260.00$429,520-0.74%
2022-08-09SaleEVP and General Counsel
7,295
0.0026%
$260.44$1.9M-0.74%
2022-06-07SaleVP Controller & Chief Acct Off
443
0.0002%
$260.00$115,180-3.38%
2022-05-06SaleEVP & President, Life Sciences
950
0.0003%
$256.00$243,200-3.17%
2022-02-25SaleEVP HR & CHRO
601
0.0002%
$271.90$163,412-4.92%
2022-02-08Saledirector
841
0.0003%
$271.70$228,500-5.95%

Insider Historical Profitability

6.05%
OVERLOCK WILARD J JRdirector
21091
0.0073%
$224.8322+1.24%
UGGLAS MARGERETHA AFdirector
10000
0.0035%
$224.8310+22.54%
BURZIK CATHERINE Mdirector
10007
0.0035%
$224.8331+5.53%
Minehan Cathy E.director
3000
0.001%
$224.8320+2.05%
Melcher David Fdirector
2728
0.0009%
$224.8310+8.76%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
The Vanguard Group$6.48B9.0626.18M+0.23%+$15.17M0.12
BlackRock$5.64B7.8922.81M+0.15%+$8.37M0.12
State Street$3.35B4.6813.53M+4.77%+$152.38M0.14
Morgan Stanley$2.65B3.7110.71M+0.01%+$339,254.020.2
T. Rowe Price$2.5B3.510.12M-2.56%-$65.71M0.31
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.